Endocrinology and metabolism

Niche oral agents in type 2 diabetes

2021; 10(3): 29-32

Ryan Jalleh, Stephen Stranks

Perspectives

Sick days, type 2 diabetes and the GP

2021; 10(3): 25-28

GARY DEED

Perspectives

What’s new in assessing fracture risk?

2021; 10(3): 20-23

Nicholas A. Pocock

Medical management of acromegaly: a growth area

2021; 10(3): 13-17

Annabelle Warren, Nirupa Sachithanandan

Solid organ transplantation and endocrine sequelae. What to be aware of

2021; 10(3): 6-11

Lisa M. Raven, Jerry R. Greenfield

Perspectives

Pancreas and islet transplantation in diabetes. Who is eligible?

2021; 10(2): 28-32

Heather Burns, Charmaine Cheung, Jenny E. Gunton

Perspectives

Type 2 diabetes and multimorbidity. Factors affecting decision-making

2021; 10(2): 25-27

Rita McMorrow, Jason Chiang, GARY KILOV, RALPH AUDEHM, Jo-Anne Manski-Nankervis

Perspectives

Challenges in type 1 diabetes. Integrating emotional support into diabetes care

2021; 10(2): 19-23

Shikha M. Gray, Christel Hendrieckx

Secondary fracture prevention. Ensuring the first fracture is the last

2021; 10(2): 11-16

Kirtan Ganda, Markus J. Seibel

Androgen replacement in men. Maximising efficacy, minimising adverse effects

2021; 10(2): 4-8

NANDINI SHANKARA-NARAYANA, Ann Conway

Acute endocrine presentations in general practice

Secondary hypertension in three vignettes

2021; 10(1): 28-32

Venessa Tsang, Sue Lynn Lau

Perspectives

Albuminuria in diabetes. How low should levels go?

2021; 10(1): 25-27

Usha Panchapakesan, Carol Pollock

Perspectives

Adjunctive metformin in type 1 diabetes

2021; 10(1): 20-24

Alicia Jenkins, Andrzej Januszewski, Gary Wittert

Hormonal contraception: what’s new?

2021; 10(1): 14-18

Deborah Bateson, Kathleen McNamee

Bone health in type 2 diabetes. Managing fracture risk

2021; 10(1): 6-11

Angela Sheu, Katherine T. Tonks

Acute endocrine presentations in general practice

Amiodarone-induced thyrotoxicosis: when it becomes a storm

2020; 9(4): 33-36

Liam Clifford, Christian Girgis, Venessa Tsang

Case studies

Endocrine causes of osteoporosis. Part 3: Premature ovarian insufficiency

2020; 9(4): 29-31

Madhuni Herath, FRANCES MILAT, PHILLIP WONG

Perspectives

Prediabetes: proactive intervention to prevent or delay onset of type 2 diabetes

2020; 9(4): 25-28

Kirstine Bell

Perspectives

Androgen therapy in women: a path to be more travelled?

2020; 9(4): 19-23

Alejandra Martínez-García, Susan R. Davis

Established CVD in people with type 2 diabetes: what pharmacotherapy should be considered?

2020; 9(4): 12-17

Kenrick Blaker, Roger Chen

Diabetes in older people: how does management change?

2020; 9(4): 6-10

Kay Hau Choy, Jeff Flack

Case studies

Endocrine causes of osteoporosis. Part 2: Glucocorticoid-induced osteoporosis

2020; 9(3): 34-36

Madhuni Herath, FRANCES MILAT, PHILLIP WONG

Perspectives

Endocrinopathies of lithium: common and treatable

2020; 9(3): 29-32

Lydia S. Lamb, Katherine Samaras

Perspectives

Continuous glucose monitoring technology: understanding the benefits

2020; 9(3): 25-27

Amin Sharifi, Neale D. Cohen

Perspectives